{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:26:57Z","timestamp":1783970817989,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03488-2","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:33:38Z","timestamp":1675287218000},"page":"1629-1634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prevalence of Fabry disease in a Turkish population with chronic kidney patients"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4697-2799","authenticated-orcid":false,"given":"\u00d6zdem Kavraz","family":"Tomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-7619","authenticated-orcid":false,"given":"Ay\u015fe Zeynep","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-8928","authenticated-orcid":false,"given":"Semahat Karahisar","family":"\u015eirali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-4484","authenticated-orcid":false,"given":"Murat","family":"Duranay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0597-5822","authenticated-orcid":false,"given":"Berfu","family":"Korucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-2133","authenticated-orcid":false,"given":"Galip","family":"G\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyit \u0130brahim","family":"Akda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"3488_CR1","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00467-016-3387-4","volume":"31","author":"S Ito","year":"2016","unstructured":"Ito S, Ogura M, Kamei K, Matsuoka K, Warnock DG (2016) Significant improvement in Fabry disease podocytopathy after 3 years of treatment with agalsidase beta. Pediatr Nephrol 31:1369\u20131373. https:\/\/doi.org\/10.1007\/s00467-016-3387-4","journal-title":"Pediatr Nephrol"},{"key":"3488_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/8904_2011_14","volume":"1","author":"T Kanai","year":"2011","unstructured":"Kanai T, Yamagata T, Ito T, Odaka J, Saito T, Aoyagi J, Kobayashi M, Ohashi T, Ueda Y, Momoi MY (2011) Foot process effacement with normal urinalysis in classic Fabry disease. JIMD Rep 1:39\u201342. https:\/\/doi.org\/10.1007\/8904_2011_14","journal-title":"JIMD Rep"},{"key":"3488_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30. https:\/\/doi.org\/10.1186\/1750-1172-5-30","journal-title":"Orphanet J Rare Dis"},{"key":"3488_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/gim.0b013e31802d8321","volume":"9","author":"RY Wang","year":"2007","unstructured":"Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34\u201345. https:\/\/doi.org\/10.1097\/gim.0b013e31802d8321","journal-title":"Genet Med"},{"key":"3488_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, Sims K, Waldek S, Pastores GM, Lee P, Eng CM, Marodi L, Stanford KE, Breunig F, Wanner C, Warnock DG, Lemay RM, Germain DP, Fabry R (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112\u2013128. https:\/\/doi.org\/10.1016\/j.ymgme.2007.09.013","journal-title":"Mol Genet Metab"},{"key":"3488_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cge.12613","volume":"89","author":"L Echevarria","year":"2016","unstructured":"Echevarria L, Benistan K, Toussaint A, Dubourg O, Hagege AA, Eladari D, Jabbour F, Beldjord C, De Mazancourt P, Germain DP (2016) X-chromosome inactivation in female patients with Fabry disease. Clin Genet 89:44\u201354. https:\/\/doi.org\/10.1111\/cge.12613","journal-title":"Clin Genet"},{"key":"3488_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1742-1241.2011.02695.x","volume":"65","author":"MA Barba-Romero","year":"2011","unstructured":"Barba-Romero MA, Rivera-Gallego A, Pintos-Morell G, Spanish FOSSG (2011) Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS). Int J Clin Pract 65:903\u2013910. https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02695.x","journal-title":"Int J Clin Pract"},{"key":"3488_CR8","volume-title":"Fabry disease: perspectives from 5 years of FOS","author":"M Fuller","year":"2006","unstructured":"Fuller M, Meikle PJ, Hopwood JJ (2006) Epidemiology of lysosomal storage diseases: an overview. In: Mehta A, Beck M, Sunder-Plassmann G (eds) Fabry disease: perspectives from 5 years of FOS. Oxford"},{"key":"3488_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jmg.2008.065904","volume":"46","author":"A Mehta","year":"2009","unstructured":"Mehta A, Clarke JT, Giugliani R, Elliott P, Linhart A, Beck M, Sunder-Plassmann G, Investigators FOS (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet 46:548\u2013552. https:\/\/doi.org\/10.1136\/jmg.2008.065904","journal-title":"J Med Genet"},{"key":"3488_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, Goldfarb L, Brady RO, Balow JE, Austin Iii HA, Kopp JB (2002) Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 81:122\u2013138. https:\/\/doi.org\/10.1097\/00005792-200203000-00003","journal-title":"Medicine (Baltimore)"},{"key":"3488_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13023-016-0441-z","volume":"11","author":"M Lenders","year":"2016","unstructured":"Lenders M, Weidemann F, Kurschat C, Canaan-K\u00fchl S, Duning T, Stypmann J, Schmitz B, Reirermann S, Kramer J, Blaschke D, Wanner C, Brand S-M, Eva Brand (2016) Alpha-Galactosidase A pA143T, a non-Fabry disease-causing variant. Orphanet J Rare Dis 11:54","journal-title":"Orphanet J Rare Dis"},{"key":"3488_CR12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18708","author":"C Ferreira","year":"2021","unstructured":"Ferreira C, Massas M, Pinto F (2021) Ana luisa silva fabry disease: a atypical presentation. Cureus. https:\/\/doi.org\/10.7759\/cureus.18708","journal-title":"Cureus"},{"key":"3488_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/0886022X.2016.1254656","volume":"39","author":"Y Yenicerioglu","year":"2017","unstructured":"Yenicerioglu Y, Akdam H, Dursun B, Alp A, SaglamEyiler F, Akin D, Gun Y, Huddam B, Batmazoglu M, GibyeliGenek D, Pirincci S, Ersoy IR, Uzum A, Soypacaci Z, Tanrisev M, Colak H, DemiralSezer S, Bozkurt G, Akyildiz UO, AkyuzUnsal AI, Unubol M, Uslu M, Eryilmaz U, Gunel C, Meteoglu I, Yavasoglu I, Unsal A, Akar H, Okyay P (2017) Screening Fabry\u2019s disease in chronic kidney disease patients not on dialysis: a multicenter study. Ren Fail 39:104\u2013111. https:\/\/doi.org\/10.1080\/0886022X.2016.1254656","journal-title":"Ren Fail"},{"key":"3488_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","volume":"52","author":"BE Smid","year":"2015","unstructured":"Smid BE, van der Tol L, Biegstraaten M, Linthorst GE, Hollak CEM, Poorthuis BJHM (2015) Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. J Med Genet 52:262\u2013268","journal-title":"J Med Genet"},{"key":"3488_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","volume":"100","author":"T Togawa","year":"2010","unstructured":"Togawa T, Kodama T, Suzuki T, Sugawara K, Tsukimura T, Ohashi T, Ishige N, Suzuki K, Kitagawa T, Sakuraba H (2010) Plasma globotriaosylsphingosine as a biomarker of Fabry disease. Mol Genet Metab 100:257\u2013261","journal-title":"Mol Genet Metab"},{"key":"3488_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ymgme.2017.07.002","volume":"123","author":"A Nowak","year":"2018","unstructured":"Nowak A, Mechtler TP, Hornemann T, Gawinecka J, Theswet E, Hilz MJ, Kasper DC (2018) Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease. Mol Genet Metab 123:148\u2013153","journal-title":"Mol Genet Metab"},{"key":"3488_CR17","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1159\/000494678","volume":"43","author":"C-J Lina","year":"2018","unstructured":"Lina C-J, Chienc Y-H, Laid T-S, Shiha H-M, Chena Y-C, Pana C-F, Chena H-H, Hwuc W-L, Wu C-J (2018) Results of fabry disease screening in male pre-end stage renal disease patients with unknown etiology found through the platform of a chronic kidney disease education program in a Northern Taiwan Medical Center. Kidney Blood Press Res 43:1636\u20131645","journal-title":"Kidney Blood Press Res"},{"key":"3488_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1186\/s13104-015-1696-5","volume":"8","author":"A Pisani","year":"2015","unstructured":"Pisani A, Daniele A, Di Domenico C, Nigro E, Salvatore F, Riccio E (2015) Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease. BMC Res Notes 8:711","journal-title":"BMC Res Notes"},{"key":"3488_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5414\/CN108672","volume":"85","author":"EI Sayilar","year":"2016","unstructured":"Sayilar EI, Ayar Y, Yavuz M (2016) Prevalence of Fabry disease among Turkish dialysis patients: data from hemodialysis centers in Bursa province. Clin Nephrol 85:165\u2013172. https:\/\/doi.org\/10.5414\/CN108672","journal-title":"Clin Nephrol"},{"key":"3488_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jmd2.12035","volume":"48","author":"J Frabasil","year":"2019","unstructured":"Frabasil J, Durand C, Sokn S, Gaggioli D, Carozza P, Carabajal R, Politei J, Schenone AB (2019) Prevalence of Fabry disease in male dialysis patients: argentinean screening study. JIMD Rep 48:45\u201352. https:\/\/doi.org\/10.1002\/jmd2.12035","journal-title":"JIMD Rep"},{"key":"3488_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/08860220802353777","volume":"30","author":"DB Porsch","year":"2008","unstructured":"Porsch DB, Nunes AC, Milani V, Rossato LB, Mattos CB, Tsao M, Netto C, Burin M, Pereira F, Matte U, Giugliani R, Barros EJ (2008) Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report. Ren Fail 30:825\u2013830. https:\/\/doi.org\/10.1080\/08860220802353777","journal-title":"Ren Fail"},{"key":"3488_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s10157-015-1146-7","volume":"20","author":"O Saito","year":"2016","unstructured":"Saito O, Kusano E, Akimoto T, Asano Y, Kitagawa T, Suzuki K, Ishige N, Akiba T, Saito A, Ishimura E, Hattori M, Hishida A, Guili C, Maruyama H, Kobayashi M, Ohashi T, Matsuda I, Eto Y (2016) Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST). Clin Exp Nephrol 20:284\u2013293. https:\/\/doi.org\/10.1007\/s10157-015-1146-7","journal-title":"Clin Exp Nephrol"},{"key":"3488_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","volume":"91","author":"R Schiffmann","year":"2017","unstructured":"Schiffmann R, Hughes DA, Linthorst GE, Ortiz A, Svarstad E, Warnock DG, West ML, Wanner C, Conference P (2017) Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201ckidney disease: improving global outcomes\u201d (KDIGO) controversies conference. Kidney Int 91:284\u2013293. https:\/\/doi.org\/10.1016\/j.kint.2016.10.004","journal-title":"Kidney Int"},{"key":"3488_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s101570050061","volume":"4","author":"K Utsumi","year":"2000","unstructured":"Utsumi K, Kase R, Takata T, Sakuraba H, Matsui N, Saito H, Nakamura T, Kawabe M, Iino Y, Katayama Y (2000) Fabry disease in patients receiving maintenance dialysis. Clin Exp Nephrol 4:49\u201351. https:\/\/doi.org\/10.1007\/s101570050061","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"3488_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.asn.0000124671.61963.1e","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtlander T, Auinger M, Pagliardini S, Spada M, Demmelbauer K, Lorenz M, Hauser AC, Kofler HJ, Lhotta K, Neyer U, Pronai W, Wallner M, Wieser C, Wiesholzer M, Zodl H, Fodinger M, Sunder-Plassmann G (2004) Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 15(5):1323\u20131329. https:\/\/doi.org\/10.1097\/01.asn.0000124671.61963.1e","journal-title":"J Am Soc Nephrol"},{"key":"3488_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gene.2013.05.050","volume":"527","author":"I Okur","year":"2013","unstructured":"Okur I, Ezgu F, Biberoglu G, Tumer L, Erten Y, Isitman M, Eminoglu FT, Hasanoglu A (2013) Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation. Gene 527:42\u201347. https:\/\/doi.org\/10.1016\/j.gene.2013.05.050","journal-title":"Gene"},{"key":"3488_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000496620","volume":"142","author":"SF Yalin","year":"2019","unstructured":"Yalin SF, Eren N, Sinangil A, Yilmaz VT, Tatar E, Ucar AR, Sevinc M, Can O, Gurkan A, Arik N, AlisirEcder S, Uyar M, Yasar M, Gulcicek S, Mese M, Dheir H, Cakir U, KoksalCevher S, Turkmen K, Guven B, GuvenTaymez D, Erkalma Senates B, Ecder T, Kocak H, Uslu A, Demir E, Basturk T, Ogutmen MB, Kinalp C, Dursun B, BicikBahcebasi Z, Sipahi S, Dede F, Oruc M, Caliskan Y, Genc A, Yelken B, Altiparmak MR, Turkmen A, Seyahi N (2019) Fabry disease prevalence in renal replacement therapy in Turkey. Nephron 142:26\u201333. https:\/\/doi.org\/10.1159\/000496620","journal-title":"Nephron"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03488-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:53:47Z","timestamp":1684166027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03488-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["3488"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03488-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"29 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}